Dr. Anupama Chawla
Claim this profileStony Brook University Medical Center
Studies Inflammatory Bowel Disease
Studies Ulcer
2 reported clinical trials
1 drug studied
Affiliated Hospitals
Clinical Trials Anupama Chawla is currently running
Vedolizumab
for Crohn's Disease
Vedolizumab is a medicine that helps to reduce inflammation and pain in the digestive system. In this study, children and teenagers with moderate to severe Crohn's disease will be treated with vedolizumab. The main aim of the study is to check if participants achieve remission after treatment with the vedolizumab. Remission means symptoms improve or disappear and an endoscopy shows no signs of inflammation. Participants will receive 3 infusions of vedolizumab over 6 weeks. Then, those who have a clinical response will receive either a high dose or low dose of vedolizumab once every 8 weeks. They will receive the same dose every time.
Recruiting2 awards Phase 36 criteria
Vedolizumab
for Ulcerative Colitis
Vedolizumab is a medicine that helps to reduce inflammation and pain in the digestive system. In this study, children and teenagers with moderate to severe ulcerative colitis will be treated with vedolizumab. The main aim of the study is to check if participants achieve remission after treatment with vedolizumab. Remission means symptoms improve or disappear and an endoscopy shows no or limited signs of disease. The study is also evaluating side effects of vedolizumab in the children and teenager with moderately to severely active ulcerative colitis. Participants will receive 3 infusions of vedolizumab over 6 weeks. Then, those who have a clinical response will receive 1 of 3 doses of vedolizumab once every 8 weeks. They will receive the same dose every time.
Recruiting2 awards Phase 37 criteria
More about Anupama Chawla
Clinical Trial Related2 years of experience running clinical trials · Led 2 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Anupama Chawla has experience with
- Vedolizumab
Breakdown of trials Anupama Chawla has run
Inflammatory Bowel Disease
Ulcerative Colitis
Crohn's Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Anupama Chawla specialize in?
Anupama Chawla focuses on Inflammatory Bowel Disease and Ulcer. In particular, much of their work with Inflammatory Bowel Disease has involved treating patients, or patients who are undergoing treatment.
Is Anupama Chawla currently recruiting for clinical trials?
Yes, Anupama Chawla is currently recruiting for 2 clinical trials in Stony Brook New York. If you're interested in participating, you should apply.
Are there any treatments that Anupama Chawla has studied deeply?
Yes, Anupama Chawla has studied treatments such as Vedolizumab.
What is the best way to schedule an appointment with Anupama Chawla?
Apply for one of the trials that Anupama Chawla is conducting.
What is the office address of Anupama Chawla?
The office of Anupama Chawla is located at: Stony Brook University Medical Center, Stony Brook, New York 11794-0001 United States. This is the address for their practice at the Stony Brook University Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.